PMDA
- Application: Orfadin
- Local brand name: Orfadin
- Status: approved
Nitisinone in Arm A (Nitisinone in Arm A) regulatory status in Japan.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. PMDA has authorised it.
Swedish Orphan Biovitrum is the originator. The local marketing authorisation holder may differ — check the official source linked above.